MARKET

ATAI

ATAI

Atai Life Sciences B.V.
NASDAQ
1.790
+0.060
+3.47%
Closed 19:57 03/27 EDT
OPEN
1.800
PREV CLOSE
1.730
HIGH
1.830
LOW
1.680
VOLUME
1.34M
TURNOVER
0
52 WEEK HIGH
2.390
52 WEEK LOW
1.025
MARKET CAP
297.16M
P/E (TTM)
-3.8981
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ATAI last week (0318-0322)?
Weekly Report · 2d ago
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement. Psychedelics biopharma company Cybin Inc. Announced that the FDA has granted it a breakthrough therapy designation for its LSD-based treatment for anxiety disorder. The company also announced the pricing of an underwritten offering of $175 million in shares.
Benzinga · 03/20 18:49
Weekly Report: what happened at ATAI last week (0311-0315)?
Weekly Report · 03/18 12:09
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Benzinga's psychedelic headlines roundup includes a look at the first two weeks of March 2024. Psychedelics are associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. A new podcast by Plantscendence hosted by James Fadiman is out. A university in Israel has received clearance for its psychedelic-based clinical trial in Israel.
Benzinga · 03/16 13:58
'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
Indiana lawmakers have sent a bill to the governor's desk to fund psychedelic research. The bill includes provisions to fund studies into psilocybin as a treatment for mental health conditions. The state is one of a growing number of states pursuing reform on psychedelics. Indiana lawmakers have been considering marijuana legalization.
Benzinga · 03/14 16:42
Aveanna Healthcare (AVAH) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/14 11:55
Weekly Report: what happened at ATAI last week (0304-0308)?
Weekly Report · 03/11 12:04
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation. U.S. FDA issued breakthrough therapy designation for its LSD formulation for generalized anxiety disorder. After the announcement, Mind Medicine stock surged 55% to reach a new 52-week high. Other companies focused on psychedelic drugs also traded higher on Thursday.
Seeking Alpha · 03/07 16:29
More
About ATAI
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.

Webull offers ATAI Life Sciences NV stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.